| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $40.0M | +50.7% |
| R&D Expense | $38.6M | +52.5% |
| SG&A Expense | $39.8M | +35.4% |
| Operating Income | -$25.9M | -203.1% |
| Pre-tax Income | -$23.8M | -176.0% |
| Income Tax | -$3.9M | +53.2% |
| Net Income | -$19.9M | -5817.9% |
| EPS (Basic) | -$0.10 | — |
| EPS (Diluted) | -$0.10 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.6M | -30.8% |
| Short-term Investments | $54.4M | — |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $189.1M | -8.0% |
| Total Assets | $189.2M | -21.4% |
| Current Liabilities | $31.0M | +167.8% |
| Total Liabilities | $31.0M | -55.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.9M | +136.1% |
| Investing Cash Flow | -$54.0M | — |
| Financing Cash Flow | $1K | -100.0% |
| — |
| Stockholders' Equity |
| $158.2M |
| -7.9% |